RxDoctor Payments Data

Amanda Wilbourn

Family · Cartersville, GANPI 1619791381

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 44 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AstraZeneca at 25.3% of the total.

$1,092in general payments, 2019–2025

Across 44 payments — averaging $24.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$276
  • Daiichi Sankyo Inc.$123
  • Merck$97
  • Incyte Corporation$69
  • Johnson & Johnson$56
  • Eisai Inc.$51
  • plus $420 from 17 others

What the payments were for

  • Food & beverage$1,092100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,092 in reported general payments places this provider in the 65th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia →

Other family in Cartersville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →